Basic Study
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Clin Oncol
7(6):425-432.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.425
Abstract (1005)
|
Core Tip (858)
|
Full Article (HTML) (3278)
|
Figures (1-2) (200)
|
Tables (1-2) (177)
|
Full Article (PDF)-2061K (407)
|
Audio-594K (17)
|
Peer-Review Report-120K (208)
|
Answering Reviewers-141K (245)
|
Received: 06/20/2016
|
Revised: 08/12/2016
|
Accepted: 10/27/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (11220)
|
Similar Articles (89)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Clin Oncol
7(6):433-440.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.433
Abstract (1005)
|
Core Tip (943)
|
Full Article (HTML) (3519)
|
Figures (1-3) (307)
|
Tables (1-2) (210)
|
Full Article (PDF)-1143K (449)
|
Audio-1781K (20)
|
Peer-Review Report-120K (232)
|
Answering Reviewers-566K (311)
|
Received: 08/03/2016
|
Revised: 09/10/2016
|
Accepted: 10/18/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (13803)
|
Similar Articles (894)
|
Timeline of Article Publication (0)
|
Authors Evaluation (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open